PA8520001A1 - Nuevo procedimiento para la preparacion de pirazolopirimidinonas - Google Patents

Nuevo procedimiento para la preparacion de pirazolopirimidinonas

Info

Publication number
PA8520001A1
PA8520001A1 PA20018520001A PA8520001A PA8520001A1 PA 8520001 A1 PA8520001 A1 PA 8520001A1 PA 20018520001 A PA20018520001 A PA 20018520001A PA 8520001 A PA8520001 A PA 8520001A PA 8520001 A1 PA8520001 A1 PA 8520001A1
Authority
PA
Panama
Prior art keywords
pirazolopirimidinonas
preparation
new procedure
procedure
general formula
Prior art date
Application number
PA20018520001A
Other languages
English (en)
Inventor
Mark Edward Bunnage
Philip Charles Levett
Nicholas Murray Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8520001(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015462A external-priority patent/GB0015462D0/en
Priority claimed from GB0105878A external-priority patent/GB0105878D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PA8520001A1 publication Critical patent/PA8520001A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE PROPORCIONA UN PROCEDIMIENTO PARA LA PRODUCCION DE UN COMPUESTO DE FORMULA GENERAL I: EN LA QUE A, R1, R2, R3 Y R4 TIENEN LOS SIGNIFICADOS PROPORCIONADOS EN LA DESCRIPCION, PROCEDIMIENTO QUE COMPRENDE LA DESHIDROGENACION DE UN COMPUESTO DE FORMULA GENERAL II.
PA20018520001A 2000-06-22 2001-06-19 Nuevo procedimiento para la preparacion de pirazolopirimidinonas PA8520001A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0015462A GB0015462D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105878A GB0105878D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazoloprimidinones

Publications (1)

Publication Number Publication Date
PA8520001A1 true PA8520001A1 (es) 2003-09-05

Family

ID=26244537

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018520001A PA8520001A1 (es) 2000-06-22 2001-06-19 Nuevo procedimiento para la preparacion de pirazolopirimidinonas

Country Status (26)

Country Link
EP (1) EP1296983B1 (es)
JP (1) JP2004501154A (es)
KR (1) KR100525699B1 (es)
AP (1) AP2001002195A0 (es)
AR (1) AR028729A1 (es)
AT (1) ATE282619T1 (es)
AU (2) AU6259201A (es)
BR (1) BR0111864A (es)
CA (1) CA2411957C (es)
CZ (1) CZ20024130A3 (es)
DE (1) DE60107248T2 (es)
ES (1) ES2231498T3 (es)
GT (2) GT200100113AA (es)
HK (1) HK1079198A1 (es)
HU (1) HUP0301207A3 (es)
IL (1) IL152983A0 (es)
MX (1) MXPA02012887A (es)
MY (1) MY127737A (es)
PA (1) PA8520001A1 (es)
PE (1) PE20020091A1 (es)
PL (1) PL360299A1 (es)
PT (1) PT1296983E (es)
SV (1) SV2002000502A (es)
TN (1) TNSN01092A1 (es)
WO (1) WO2001098303A1 (es)
YU (1) YU84702A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
DE69911448T2 (de) * 1998-10-23 2004-04-08 Pfizer Inc. Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen

Also Published As

Publication number Publication date
JP2004501154A (ja) 2004-01-15
KR100525699B1 (ko) 2005-11-03
GT200100113A (es) 2002-06-04
YU84702A (sh) 2005-09-19
TNSN01092A1 (fr) 2005-11-10
AU6259201A (en) 2002-01-02
CA2411957A1 (en) 2001-12-27
KR20030017556A (ko) 2003-03-03
IL152983A0 (en) 2003-06-24
DE60107248T2 (de) 2005-12-01
CA2411957C (en) 2007-09-18
DE60107248D1 (de) 2004-12-23
PL360299A1 (en) 2004-09-06
ATE282619T1 (de) 2004-12-15
PT1296983E (pt) 2005-02-28
SV2002000502A (es) 2002-07-03
EP1296983A1 (en) 2003-04-02
PE20020091A1 (es) 2002-02-21
ES2231498T3 (es) 2005-05-16
CZ20024130A3 (cs) 2004-01-14
MY127737A (en) 2006-12-29
EP1296983B1 (en) 2004-11-17
AP2001002195A0 (en) 2002-12-21
HK1079198A1 (en) 2006-03-31
MXPA02012887A (es) 2003-05-14
AU2001262592B2 (en) 2006-07-06
WO2001098303A1 (en) 2001-12-27
BR0111864A (pt) 2003-07-01
HUP0301207A3 (en) 2006-02-28
HUP0301207A2 (hu) 2003-08-28
GT200100113AA (es) 2006-04-10
AR028729A1 (es) 2003-05-21

Similar Documents

Publication Publication Date Title
SE0000540D0 (sv) New compounds
HN2002000300A (es) Nuevos derivados de piperazina
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
MXPA02012076A (es) Compuestos quimicos.
YU75601A (sh) Postupak za pripremanje modulatora nesteroidnih glukokortikoidnih receptora
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
BR0109542A (pt) Derivados de imidazopirina alquilados
HN2001000235A (es) Derivados puentes de piperazina
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
PA8519801A1 (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
PA8520001A1 (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
UY26556A1 (es) Compuestos calcilíticos
BR0110490A (pt) Agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina
SV2002000302A (es) Nuevos derivados de amidas heterociclicas ref. pc 10561/20140/bb
UY26786A1 (es) Nuevo procedimiento para la preparación de pirazolopirimidinonas
BR0104738A (pt) Beta-hidroxialquilamidas, processo para sua produção e seu uso
DOP2001000186A (es) Nuevo procedimiento para la preparación de pirazolopirimidinonas